Medical and Pharmaceutical Aerosols - Aerosols: Measurement, Dosimetry, and Health Effects - page 26

132. Niven, R.W., Ip, A.Y., Mittelman, S., Prestrelski, S.J., and Arakawa, T. Some factors associated with the
ultrasonic nebulization of proteins. Pharmaceutical Research 12 , 53-59 (1995).
133. Steckel, H., Eskandar, F., and Witthohn, K. Effect of excipients on the stability and aerosol performance
of nebulized aviscumine. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 16 ,
417-432 (2003).
134. Niven, R.W., Whitcomb, K.L., Woodward, M., Liu, J., and Jornacion, C. Systemic absorption and activ-
ity of recombinant consensus interferons after intratracheal instillation and aerosol administration.
Pharmaceutical Research 12 , 1889-1895 (1995).
135. Niven, R.W., Whitcomb, K.L., Shaner, L., Ip, A.Y., and Kinstler, O.B. The pulmonary absorption of aero-
solized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSF. Pharmaceutical Research
12 , 1343-1349 (1995).
136. Cipolla, D.C. et al. Coarse spray delivery to a localized region of the pulmonary airways for gene therapy.
Human Gene Therapy 11 , 361-371 (2000).
137. Dolovich, M. New propellant-free technologies under investigation. Journal of Aerosol Medicine
12(Suppl. 1) , S9-S17 (1999).
138. Hickey, A.J. and Swift, D. Characterization of pharmaceutical and diagnostic aerosols. In: Baron, P.A.
and Willeke, K. eds. Aerosol Measurement: Principles, Techniques and Applications . Wiley: New York,
pp. 1031-1052 (2001).
139. Finnin, B. and Morgan, T. Transdermal penetration enhancers: Applications, limitations, and potential.
Journal of Pharmaceutical Sciences 88 , 955-958 (1999).
140. Chik, Z. et al. Pharmacokinetics of a new testosterone transdermal delivery system, TDS (R)-testosterone
in healthy males. British Journal of Clinical Pharmacology 61 , 275-279 (2006).
141. Li, X. et al. Development of patch and spray formulations for enhancing topical delivery of sinomenine
hydrochloride. Journal of Pharmaceutical Sciences 99 , 1790-1799 (2010).
142. Lahm, K. and Lee, G. Penetration of crystalline powder particles into excised human skin membranes
and model gels from a supersonic powder injector. Journal of Pharmaceutical Sciences 95 , 1511-1526
(2006).
143. Dorey, E. PowderMed to trial three vaccines. Chemistry and Industry 21, 5 (2004).
144. Gonda, I. Targeting by deposition. In: Hickey, A.J., ed. Pharmaceutical Inhalation Aerosol Technology .
Marcel Dekker: New York, pp. 61-82 (1992).
145. Esmen, N.A. and Lee, T.C. Distortion of cascade impactor measured size distribution due to bounce and
blow-off. American Industrial Hygiene Association Journal 41 , 410-419 (1980).
146. Marple, V. et al. Next generation pharmaceutical impactor: A new impactor for pharmaceutical inhaler
testing. Part I: Design. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 16 ,
283-299 (2003).
147. Marple, V. et al. Next generation pharmaceutical impactor: A new impactor for pharmaceutical inhaler
testing. Part II: Archival calibration. Journal of Aerosol Medicine-Deposition Clearance and Effects in
the Lung 16 , 301-324 (2003).
148. Marple, V. et al. Next generation pharmaceutical impactor: A new impactor for pharmaceutical inhaler
testing. Part III. Extension of archival calibration to 15 L/min. Journal of Aerosol Medicine-Deposition
Clearance and Effects in the Lung 17 , 335-343 (2004).
149. Hallworth, G.W. and Andrews, U.G. Size analysis of suspension inhalation aerosols by inertial separation
methods. Journal of Pharmacy and Pharmacology 28 , 898-907 (1976).
150. Rubow, K.L., Marple, V.A., Olin, J., and Mccawley, M.A. A personal cascade impactor: Design, evalua-
tion and calibration. American Industrial Hygiene Association Journal 48 , 532-538 (1987).
151. Williams, R.O.3. and Hu, C. Moisture uptake and its inluence on pressurized metered-dose inhalers.
(2000). At http://informahealthcare.com/doi/abs/10.1081/PDT-100100530
152. Clarke, M.J., Tobyn, M.J., and Staniforth, J.N. The formulation of powder inhalation systems contain-
ing a high mass of nedocromil sodium trihydrate. Journal of Pharmaceutical Sciences 90 , 213-223
(2001).
153. Evans, R. Determination of drug particle size and morphology using optical microscopy. Pharmaceutical
Technology 17 , 146-146 (1993).
154. Ranucci, J.A. and Chen, F.C. Phase Doppler anemometry: A technique for determining aerosol plume-
particle size and velocity. Pharmaceutical Technology 17 , 62-62 (1993).
155. Dunbar, C.A. and Hickey, A.J. Selected parameters affecting characterization of nebulized aqueous
solutions by inertial impaction and comparison with phase-Doppler analysis. European Journal of
Pharmaceutics and Biopharmaceutics 48 , 171-177 (1999).